164 related articles for article (PubMed ID: 9620903)
1. Circulating immunoreactive interleukin-6 in cystic fibrosis.
Nixon LS; Yung B; Bell SC; Elborn JS; Shale DJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1764-9. PubMed ID: 9620903
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.
Jones AM; Martin L; Bright-Thomas RJ; Dodd ME; McDowell A; Moffitt KL; Elborn JS; Webb AK
Eur Respir J; 2003 Sep; 22(3):503-6. PubMed ID: 14516142
[TBL] [Abstract][Full Text] [Related]
3. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
4. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
5. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in sputum and serum from patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs.
Kronborg G; Hansen MB; Svenson M; Fomsgaard A; Høiby N; Bendtzen K
Pediatr Pulmonol; 1993 May; 15(5):292-7. PubMed ID: 8327288
[TBL] [Abstract][Full Text] [Related]
7. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil mediators, Pseudomonas, and pulmonary dysfunction in cystic fibrosis.
Meyer KC; Zimmerman J
J Lab Clin Med; 1993 May; 121(5):654-61. PubMed ID: 8386737
[TBL] [Abstract][Full Text] [Related]
9. Plasma tumour necrosis factor alpha in cystic fibrosis.
Norman D; Elborn JS; Cordon SM; Rayner RJ; Wiseman MS; Hiller EJ; Shale DJ
Thorax; 1991 Feb; 46(2):91-5. PubMed ID: 2014508
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
Pukhalsky AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Shabalova LA; Kokarovtseva SN; Pukhalskaya DA; Kashirskaja NJ; Simonova OI
Mediators Inflamm; 1999; 8(3):159-67. PubMed ID: 10704054
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
12. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
13. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.
Wolter JM; Rodwell RL; Bowler SD; McCormack JG
Clin Diagn Lab Immunol; 1999 Mar; 6(2):260-5. PubMed ID: 10066664
[TBL] [Abstract][Full Text] [Related]
14. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
15. The relationship of clinical and inflammatory markers to outcome in stable patients with cystic fibrosis.
Downey DG; Martin SL; Dempster M; Moore JE; Keogan MT; Starcher B; Edgar J; Bilton D; Elborn JS
Pediatr Pulmonol; 2007 Mar; 42(3):216-20. PubMed ID: 17238189
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress during acute respiratory exacerbations in cystic fibrosis.
McGrath LT; Mallon P; Dowey L; Silke B; McClean E; McDonnell M; Devine A; Copeland S; Elborn S
Thorax; 1999 Jun; 54(6):518-23. PubMed ID: 10335006
[TBL] [Abstract][Full Text] [Related]
17. Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis.
Sagel SD; Kapsner RK; Osberg I
Pediatr Pulmonol; 2005 Mar; 39(3):224-32. PubMed ID: 15635615
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis.
Elborn JS; Cordon SM; Western PJ; Macdonald IA; Shale DJ
Clin Sci (Lond); 1993 Nov; 85(5):563-8. PubMed ID: 8287644
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory markers in cystic fibrosis.
Rayner RJ; Wiseman MS; Cordon SM; Norman D; Hiller EJ; Shale DJ
Respir Med; 1991 Mar; 85(2):139-45. PubMed ID: 1887131
[TBL] [Abstract][Full Text] [Related]
20. Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: preliminary observations.
Aronoff SC; Quinn FJ; Carpenter LS; Novick WJ
J Pediatr; 1994 Dec; 125(6 Pt 1):992-7. PubMed ID: 7996376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
